Adding ezetimibe to a statin lowers CRP by an extra 10% in pooled trials
Pooled analysis of placebo-controlled ezetimibe trials found ezetimibe alone lowered CRP numerically more than placebo (6%, not significant), while added to statin therapy it gave a significant extra 10% CRP reduction. Gokhan lists related studies on ezetimibe's anti-inflammatory effects.


